- Home
- / HLB Science
HLB Science
HLB Science Summary
Company Summary
- Overview
- HLB Science (HLB사이언스주식회사, formerly known as DanDi Bioscience) is a company that develops biological drugs with a mechanism of action (MoA) for infectious diseases. It mostly provides sepsis therapeutics and Alzheimer's disease cure solutions.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2016
- HQ
- Seoul, KR | view all locations
- Cybersecurity rating
Table of Contents
Key People
Operating MetricsView all
Drugs in Development
3
Jun, 2023
LocationsView all
1 location detected
Seoul, Seoul HQ
Korea (Republic of)
6f, 66 Achasan-ro, Seongdong-gu
HLB Science Financials
Summary Financials
- Gross profit (FY, 2024)
- ₩17.6M
- Net income (FY, 2024)
- (₩2.3B)
- Cash (FY, 2024)
- ₩1.0B
- EBIT (FY, 2024)
- (₩2.1B)